期刊文献+

术前服用盐酸安妥沙星后患者被切除肺组织中药物浓度分析

Concentrations of Preoperative Oral Antofloxacin Hydrochloride in Patients after Resection of Lung Tissue were Analyzed
原文传递
导出
摘要 目的研究盐酸安妥沙星口服400 mg在肺组织中药物浓度,初步评价术前应用口服单剂盐酸安妥沙星400 mg作为肺叶切除术预防感染用药的可靠性。方法选取2011年1月至2013年8月肺叶切除术患者48例,按距离支气管离断前时间不同随机分为4、8、12、24 h给药共4组,口服盐酸安妥沙星400 mg,收集血液标本和肺组织标本,采用高效液相色谱法测定血浆及肺组织中药物浓度。结果 4、8、12、24 h组血浆和肺组织中药物浓度分别为(3.281±0.817)μg·mL-1和(5.992±3.228)μg·g-1、(3.192±0.953)μg·mL-1和(5.885±2.952)μg·g-1、(1.712±0.576)μg·mL-1和(3.419±1.107)μg·g-1、(0.431±0.095)μg·mL-1和(1.258±0.306)μg·g-1。结论口服盐酸安妥沙星后药物在肺组织中药物清除时间大于血浆药物清除时间,肺叶切除术术前12 h内口服单剂盐酸安妥沙星400 mg在肺组织中的药物浓度可以达到有效抗菌作用,理论上肺叶切除术术前12 h内口服盐酸安妥沙星400 mg可以作为感染预防用药。 OBJECTIVE To determine the concentrationsof antofloxacin hydrochloride in the lung tissuesafter single dose preoperative oral administration of 400 mg in patientsreceiving pulmonry lobectomy for,preliminary evaluation of the rationality of this regimen to prevent infection. METHODS Forty-eight patients with no clinical evidence of preoperative infection undergoing pulmonary lobectomy were selected and randomized into four treatment groups. 400 mg antofloxacin hydrochloride was administered orally at 4,8, 12,and 24 h before the removal of the bronchi. Blood samples and lung tissues were collected after operation. The antofloxacin hydrochloride in blood serum and lung tissues was determined by high performance liquid chromatogram. RESULTS The average concentrations of antofloxacin hydrochloride in serum andlung tissuesin the four groupswere( 3. 281 ± 0. 817) μg · mL- 1and( 5. 992 ± 3. 228) μg·g- 1,( 3. 192 ±0. 953) μg·mL- 1and( 5. 885 ± 2. 952) μg·g- 1,( 1. 712 ±0. 576) μg·mL- 1and( 3. 419 ± 1. 107) μg·g- 1,and( 0. 431 ±0. 095) μg·mL- 1and( 1. 258 ± 0. 306) μg·g- 1,respectively. CONCLUSION The clearance time of oral antofloxacin hydrochloride in lung tissue was longer than that in serum. Single dose administration of oral antofloxacin hydrochloride 400mg within 12 h before operation can achieve effective bactericidal levels in serum and lung tissues,which could be a method to prevent infection for pulmonary lobectomy.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第10期874-876,共3页 Chinese Pharmaceutical Journal
关键词 盐酸安妥沙星 肺叶切除术 肺组织 高效液相色谱法 antofloxacin hydrochloride lobectomy lung tissue high performance liquid chromatogram
  • 相关文献

参考文献2

二级参考文献22

  • 1郭晨雯,范春,牛其昌,傅金英,王颖.1999~2003年铜绿假单胞菌耐药性变迁的分析[J].中华医院感染学杂志,2005,15(8):940-942. 被引量:45
  • 2徐海燕,王海军,刘颖珍,高勇,肖庆龙.外科术后真菌感染分析[J].中华医院感染学杂志,2006,16(4):389-390. 被引量:14
  • 3郑文香,韩斌.浅议临床标本微生物检验阳性率低的原因[J].卫生职业教育,2007,25(10):110-110. 被引量:6
  • 4Clinical and Laboratory Standards Institute. Performance standards for anti- microbial susceptibility testing, nineteenth informational supplement [ D ]. M100-S19. Wayne, PA :CLSI, 2009.
  • 5Inga Odenhoh, Elisabeth L~wdin, Otto Cars. Postantibiotic, Postantibi- otic Sub-MIC, and Subinhibitory Effects ofPGE-9509924, Cipreffoxacin, andLevofloxacin[ J ]. Antmicrob Agents Chemother, 2003,47 : 3352- 3356.
  • 6Inga Odenhalt, Tomqvist. Studies on the postantibiotic effect and the postan- tibiotic sub-MIC effect of meropenem [ J ]. Antmicrobial Chemotherapy, 1993,31:881-892.
  • 7Craig WA. Pharmaeodynamics of antimicrobial agents as a basis for detemli- ning dosage regimens[ J]. Clin Microbial infect Dis, 1993,12:86-88.
  • 8Robert C, Owens Jr, Andrew F, et al. Rational dosing of antimicrobial a- gents : Phaimacokinetie and pharmaeodynamic strategies [ J ]. Heahh-Syst Pharm, 2009, 66(4) :S23-30.
  • 9Inga Odenhoh. Pharmacodynamie effects of subinhibitory antibiotic concen- trations [ J ]. Journal of Antimicrobial Agents, 2001,17 : 1-8.
  • 10Vanessa R, Anderson, Caroline M, et al. Levofloxaein A Review of its Use as a High-Dose, Short-Course Treatment for Bacterial Infection[ J ]. Drags, 2008, 68 (4) :535-565.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部